Abstract

The question, "Is cancer hereditary?" has been answered beyond any doubt through the discovery of germ-line cancer-causing mutations in a subset of colorectal cancers (CRCs). Clearly, this authentication of the role of genetics was not solely dependent on molecular genetic studies, since hereditary cancer syndromes such as familial adenomatous polyposis (FAP) had been known for at least 100 years, but molecular advances are clarifying and refining clinical impressions. Have clinicians acted on the importance of hereditary factors in cancer so that this knowledge might be translated into patient benefit? Data showing that 59% of patients with FAP still die of metastatic CRC suggest that the answer is no.

Keywords

MedicineFamilial adenomatous polyposisColorectal cancerCancerGermlineGermline mutationOncologyMutationInternal medicineGeneticsGeneBiology

Affiliated Institutions

Related Publications

Publication Info

Year
2003
Type
review
Volume
348
Issue
10
Pages
919-932
Citations
2165
Access
Closed

External Links

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

2165
OpenAlex

Cite This

Henry T. Lynch, Albert de la Chapelle (2003). Hereditary Colorectal Cancer. New England Journal of Medicine , 348 (10) , 919-932. https://doi.org/10.1056/nejmra012242

Identifiers

DOI
10.1056/nejmra012242